CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

GS1 Standards: Making Pharmacy Fit for the Future

As our healthcare system faces increasing pressure to improve safety and efficiency, and to be a world leader in delivering care, for pharmacy this translates into the challenge of keeping medicines safe, using them more cost-effectively and keeping up to date with the latest legislation and technology. Counterfeit drugs are a global problem, and medicines spend is one of the biggest costs to the NHS. Legislation such as the Falsified Medicines Directive will make our pharmacies safer and central initiatives such as the Global Digital Exemplar programme are pushing Trusts to stay ahead of the game in their use of data and technology – Glen Hodgson from GS1 suggests that GS1 standards are key to both.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026